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Vitiligo is a common skin disorder that manifests as whitish macules. There 
is no special geographic or sex predilection. Vitiligo is a multifactorial disorder. 
The various theories proposed include neutral theory, autoimmune theory, zinc-
α2-glycoprotein theory, viral infection, intrinsic theory and melanocytorrhagy 
theory. However, the currently favored opinion is that there is a convergence of 
various theories known as the convergence theory. The basic defect is the absence 
of functional melanocytes from the epidermal melanin unit. This absence can be 
demonstrated by using special stains like Fontana-Masson, immunohistochem-
istry like HMB-45 and Melan-A and electron microscopy. Margins of lesions 
especially early lesions show inflammatory cells principally CD4+ and CD8+ T 
cells. The cornerstone of management in vitiligo is correct categorization of a 
case into stable and unstable vitiligo. This distinction is based mainly on clini-
cal criteria. It is recommended that while evaluating biopsies, histopathological 
examination should be primarily concentrated on evaluating five histopathologi-
cal variables—spongiosis, epidermal lymphocytes, basal cell vacuolation, dermal 
lymphocytes and melanophages. These parameters are then scored using a 
scoring system, and the recommended diagnoses based on these scores are given. 
Adoption of a systematic reporting system brings more consistency and objectiv-
ity in the diagnosis.
Keywords: vitiligo, multifactorial, convergence theory, melanocytes,  
histological scoring
1. Introduction
Vitiligo is a common acquired, idiopathic, progressive disorder which is 
characterized by the development of depigmented milky white macules of 
variable sizes. These often enlarge and coalesce to form extensive areas of leu-
koderma [1–3]. It equally affects both sexes with a worldwide prevalence of 
0.1–2% [4]. It is a psychologically devastating and frequently resistant to treat-
ment [5, 6]. The basic defect in vitiligo is a selective destruction of functional 
melanocytes [7].
The role of histopathology in the diagnosis of vitiligo is not yet fully established. 
So much so that routinely in these cases biopsy is not performed. The diagnosis is 




Vitiligo is a multifactorial disorder [8, 9]. In its genesis both genetic and non-
genetic factors are believed to play a role. It is observed that clinically no two 
patients of vitiligo are alike. This suggests that etiology also varies among different 
patients. Due to the observed variation in clinical manifestations of the disease, it 
seems likely that etiology of vitiligo may differ among patients [10]. These several 
theories have been combined into the convergence theory [11] which is currently 
the most accepted theory.
Briefly in the earliest theory, it was proposed by Lerner that vitiligo was neural 
in origin [12]. This theory could explain the segmental form of vitiligo which fol-
lows dermatomal distribution and is associated with hyperhidrosis and emotional 
disturbances. In another study the role of sympathetic nervous system in vitiligo 
was studied [13]. It was observed that the cutaneous blood flow in the lesional skin 
was three times higher than the normal skin in cases of segmental vitiligo. However, 
in other cases of non-segmental vitiligo, this was not observed.
Studies on the expression of neural proteins like neuropeptide Y (NPY), calci-
tonin gene-related peptide (CGRP), vasoactive intestinal polypeptide (VIP) and 
polyclonal general neuronal marker (PGP) have shown variable results. In one study 
NPY expression was found to be increased in cases of segmental vitiligo [14]. It is 
proposed that precipitating factors like stress lead to increased NPY expression [15].
But this theory failed to explain the other forms of vitiligo. For that matter gen-
eralized or non-segmental vitiligo is better explained by autoimmune hypothesis. 
In previously done studies, antibodies against various targets like tyrosine hydroxy-
lase, melanin-concentrating hormone receptor-1 (MCHR1), tyrosinase [16] and 
pigment cell surface antigens [17] have been demonstrated. In a study carried out to 
evaluate the various immunoglobulins, it was observed that 80% of active vitiligo 
patients showed the presence of IgG and IgM against melanocytes [17]. Other stud-
ies have shown the presence of anti-thyroglobulin antibodies, antithyroid antibod-
ies, anti-thyroperoxidase and anti-smooth muscle antibody in these cases [18, 19].
Besides humoral immunity, cell-mediated immunity may also play an important 
role. Immunohistochemical examination of perilesional skin in vitiligo patients 
showed increased CD8:CD4 ratio and HLA-DR production along suprabasal and 
basal keratinocytes. Macrophages were found to be quite numerous [20]. However, 
not only the immune cells and antibodies but expression of various cytokines is also 
increased. Chief among these which have been studied are tumor necrosis factor-α 
(TNF-α), interferon-γ (IFN-γ) and IL-10 [21, 22]. IL-17 has also been shown to be 
significantly increased in cases of vitiligo [23].
The redox (reduction–oxidation) state of vitiliginous patients has been studied 
by many authors. These studies have shown increased serum levels of selenium, 
superoxide dismutase (SOD) and malondialdehyde (MDA) [24, 25]. Increased lev-
els of these substances indicate the presence of oxidative stress in vitiligo. Increased 
levels of tetrahydrobiopterin [26] and xanthine oxidase [27] leading to increased 
levels of H2O2 may also be contributory.
Few authors have pointed towards the role of zinc-α2-glycoprotein (ZAG) in the 
pathogenesis of vitiligo. They hypothesize that lack of ZAG causes impaired melano-
cytic adhesion to other cells in the epidermis [28, 29]. The efficacy of zinc in the treat-
ment of vitiligo may be due to its ability to precipitate ZAG at the site of vitiligo [30].
The role of viral infection in vitiligo has been proposed by certain authors. The 
potential candidates include hepatitis C virus (HCV) [31], cytomegalovirus (CMV) 
[32], Epstein–Barr virus (EBV), hepatitis e virus, herpes virus and HIV [33]. 
However, the evidence available is scant and not conclusive enough to attribute a 
significant role for viral agents in vitiligo.
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The intrinsic theory states that in vitiligo there is loss of melanocytes due to 
various abnormalities which lead to increased apoptosis [34] and accelerated cell 
senescence [35, 36]. Studies done previously have shown various abnormalities 
in the melanocytes including cytoplasmic vacuolization, DNA marginalization, 
dendrite loss and detachment [36, 37]. The evidence in favor of increased apoptosis 
in vitiligo includes reduced expression levels of the antiapoptotic proteins Bcl-2 
and FLIP in vitiliginous skin as compared to normal skin [34]. On the other hand, 
marked increase in the expression of proapoptotic factors such as Bax and p53 along 
with the various caspases has also been observed [34].
The melanocytorrhagy theory states that in vitiligo there is chronic melanocyte 
detachment and loss caused by trauma and other stressors which include catechol-
amines, free radicals or autoimmune elements [38].
However, the consensus opinion of majority of experts is that vitiligo occurs 
due to convergence of these various pathways [39]. These are also depicted in 
(Figure 1). The author also is in agreement with this view; however, it is likely that 
in various subtypes of vitiligo the relative contribution of these pathways may vary. 
For example, in segmental vitiligo the neural theory may be more relevant than the 
other theories, whereas the same may not hold true for vitiligo vulgaris.
3. Histopathology
In order to understand the histopathology of vitiligo, it is essential to first 
understand the concept of epidermal melanin unit [40]. Melanocytes are neural 
crest derivatives, and they reach their final destination of basal layer of the epider-
mis and hair follicles via a process of migration. Each melanocyte then transfers its 
melanosomes to approximately 36 keratinocytes via a unique mechanism known as 
the shedding vesicle system. In the normal skin in the basal layer of the epidermis 
for every five basal keratinocytes, there is a presence of a single melanocyte [41].
The basic histopathological finding in vitiligo is the absence of functional mela-
nocytes in the basal layer of the epidermis (Figure 2) [42–44]. This absence can 






(a) Fontana-Masson showing the presence of melanin pigment and melanocytes in the epidermis (X400). 
(b) Fontana-Masson showing the absence of melanin pigment and melanocytes in the epidermis (x400).
Immunohistochemistry for melanocyte-specific markers like HMB-45 and Melan-A 
and electron microscopy can also be performed for this purpose.
Other changes that have been observed include degenerative changes in the 
nerves and adnexa like sebaceous glands and hair follicles especially in long-stand-
ing cases [46].
In the margins of lesions especially early lesions, often inflammatory cells are 
seen. Principally, these cells comprise of CD4+ and CD8+ T cells [47]. These cells 
have been shown to demonstrate melanocyte-specific cytotoxicity [48]. At the 
margins of the lesions, melanocytes have been observed to show morphological 
changes like cellular enlargement, cytoplasmic vacuolization and long dendritic 
processes [29].
However, usually skin biopsy is not performed for making the diagnosis as it is 
primarily a clinical diagnosis. The cornerstone of its management is correct catego-
rization of a case into its two broad types—stable and unstable vitiligo. This distinc-
tion is at present based mainly on clinical criteria because the histopathological 
Figure 2. 
Vitiligo showing the absence of melanocytes in basal layer of the epidermis (H&E, X400).
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features are not fully established. In a study carried out by the author, a reliable and 
systematic approach towards this diagnostic challenge has come up [49]. In that 
study the biopsies (3-mm punch) were taken from the margin of the active lesion.
The author recommends that while evaluating biopsies from cases of vitiligo 
histopathological examination should be primarily focused on evaluating five histo-
pathological variables—spongiosis, epidermal lymphocytes, basal cell vacuolation, 
dermal lymphocytes and melanophages (Figure 4). The morphological criteria 
used to assess these parameters are listed in Table 1. All the cases are then scored 
Figure 4. 
(a) Spongiosis (H&E, x400). (b) Intraepidermal lymphocytes (H&E, x400). (c) Basal cell vacuolation 
(H&E, x400). (d) Dermal lymphocytosis (H&E, x200). (e) Dermal melanophages (H&E, x400).
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using a scoring system devised by the authors Table 2, and the recommended 
diagnoses based on these scores are shown in Table 3. The counting for dermal 
lymphocytes was done in high power (x400) of a Nikon microscope. The scoring 
system can be applied to both segmental and non-segmental vitiligo. Adoption 
of a systematic reporting system brings more consistency and objectivity in the 
diagnosis.
4. Conclusions
Vitiligo is a common skin disorder which is characterized by the presence of 
depigmented milky white macules of variable sizes. Although there are various 
theories on its etiopathogenesis, the consensus opinion is that vitiligo occurs due 
to convergence various pathways. The basic histopathological finding in vitiligo is 
the absence of functional melanocytes in the basal layer of the epidermis. However, 
in order to evaluate for stability, the histopathological examination should be 
primarily focused on evaluating spongiosis, epidermal lymphocytes, basal cell 
S. no. Histological feature Criteria
1 Spongiosis Presence of at least one focus showing intercellular oedema in the 
epidermis
2 Epidermal lymphocytes Presence of at least one lymphocyte in the epidermis
3 Basal cell vacuolation Presence of at least one focus showing basal cell degeneration in the 
form of vacuolation
4 Melanophages Presence of at least one focus in the superficial reticular dermis 
showing melanophages
Table 1. 
Histomorphological criteria for spongiosis, epidermal lymphocytes, basal cell vacuolation and melanophages.
S. no. Histological feature Observation Score
1 Spongiosis Present/absent 1/0
2 Epidermal lymphocytes Present/absent 1/0
3 Basal vacuolation Present/absent 1/0
4 Dermal lymphocytes >100 Present/absent 1/0
5 Melanophages Present/absence 1/0
Table 2. 
Vitiligo histological scoring system.
S. no. Total score Diagnosis
1. 5 Unstable vitiligo
2. 4 Unstable vitiligo
3. 3 Favours unstable, clinical correlation required
4. 2 Favours stable, clinical correlation required
5. 0–1 Strongly favours stable vitiligo, clinical correlation essential
Table 3. 
Final recommended diagnostic categories based on score.
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vacuolation, dermal lymphocytes and melanophages. It is recommended to score 
these parameters, and the final report should incorporate recommended diagnosis 
based on the score. This will bring more objectivity and consistency in reporting 
these biopsies.
Acknowledgements
The author wishes to acknowledge the help provided by Dr. Niti Khunger, 
Consultant, Dermatology, VMMC & Safdarjung Hospital, and Dr. Pallavi Mishra, 
Resident, VMMC & Safdarjung Hospital.
Conflict of interest
The author wishes to declare that there are no conflicts of interest.
Notes/thanks/other declarations
None declared.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
8Depigmentation
[1] Koranne RV, Sachdeva KG. Vitiligo. 
International Journal of Dermatology. 
1988;27:676-681
[2] Nordlund JJ, Lerner AB. Vitiligo: It 
is important. Archives of Dermatology. 
1982;118:5-8
[3] Sharquie KE. Vitiligo. Clinical 
and Experimental Dermatology. 
1984;9:117-126
[4] Handa S, Kaur I. Vitiligo: Clinical 
findings in 1436 patients. The Journal of 
Dermatology. 1999;26:653-657
[5] Namazi MR. Phenytoin as a novel 
anti-vitiligo weapon. Journal of 
Autoimmune Diseases. 2005;2:11
[6] Mantovani S, Garbelli S, Palermo B, 
et al. Molecular and functional bases of 
self-antigen recognition in long-term 
persistent melanocyte-specific CD8+ 
T cells in one vitiligo patient. The 
Journal of Investigative Dermatology. 
2003;121:308-314
[7] Xia Q , Zhou WM, Liang YH, 
et al. MHC haplotypic association in 
Chinese Han patients with vitiligo. 
Journal of the European Academy 
of Dermatology and Venereology. 
2006;20:941-946
[8] Daneshpazhooh M, Mostofizadeh  
GM, Behjati J, Akhyani M, Mahmoud 
Robati R. Anti-thyroid peroxidase 
antibody and vitiligo: A controlled 
study. BMC Dermatology. 2006;6:3
[9] Alkahateeb A, Fain PR, Thody A, 
Bennett DC, Spritz RA. Epidemiology 
of vitiligo and associated autoimmune 
disease in Caucasian probands and 
their families. Pigment Cell Research. 
2003;16:208-214
[10] Manolache L, Benea V. Stress 
in patients with alopecia areata and 
vitiligo. Journal of the European 
Academy of Dermatology and 
Venereology. 2007;21:921-928
[11] Le Poole IC, Das PK, Van den 
Wijngaard RM, Bos JD, Westerhof W. 
Review of the etiopathomechanism 
of vitiligo: A convergence theory. 
Experimental Dermatology. 
1993;2:145-153
[12] Lerner AB. Vitiligo. The Journal 
of Investigative Dermatology. 
1959;32:285-310
[13] Wu CS, Yu HS, Chang HR, Yu CL, 
Yu CL, Wu BN. Cutaneous blood flow 
and adrenoceptor response increase 
in segmental-type vitiligo lesions. 
Journal of Dermatological Science. 
2000;23:53-62
[14] Al’Abadie MS, Senior HJ, Bleehen SS, 
Gawkrodger DJ. Neuropeptide and 
neuronal marker studies in vitiligo. 
The British Journal of Dermatology. 
1994;131:160-165
[15] Yehuda R, Brand S, Yang RK. Plasma 
neuropeptide Y concentrations in 
combat exposed veterans: Relationship 
to trauma exposure, recovery 
from PTSD, and coping. Biological 
Psychiatry. 2006;59:660-663
[16] Kemp EH, Emhemad S, 
Akhtar S, Watson PF, Gawkrodger DJ, 
Weetman AP. Autoantibodies against 
tyrosine hydroxylase in patients 
with non-segmental (generalised) 
vitiligo. Experimental Dermatology. 
2011;20:35-40
[17] Harning R, Cui J, Bystryn JC. 
Relation between the incidence and 
level of pigment cell antibodies 
and disease activity in vitiligo. The 
Journal of Investigative Dermatology. 
1991;97:1078-1080
[18] Ingordo V, Gentile C, 
Iannazzone SS, Cusano F, Naldi L. Vitiligo 
References
9Histopathology and Molecular Pathology of Vitiligo
DOI: http://dx.doi.org/10.5772/intechopen.84258
and autoimmunity: An epidemiological 
study in a representative sample of 
young Italian males. Journal of the 
European Academy of Dermatology and 
Venereology. 2011;25:105-109
[19] Uncu S, Yaylı S, Bahadır S, Okten A, 
Alpay K. Relevance of autoimmune 
thyroiditis in children and adolescents 
with vitiligo. International Journal of 
Dermatology. 2011;50:175-179
[20] Le Poole IC, van den Wijngaard RM, 
Westerhof W, Das PK. Presence of T 
cells and macrophages in inflammatory 
vitiligo skin parallels melanocyte 
disappearance. The American Journal of 
Pathology. 1996;148:1219-1228
[21] Grimes PE, Morris R, 
Avaniss-Aghajani E, Soriano T, Meraz M, 
Metzger A. Topical tacrolimus therapy 
for vitiligo: Therapeutic responses and 
skin messenger RNA expression of 
proinflammatory cytokines. Journal of 
the American Academy of Dermatology. 
2004;51:52-61
[22] Taher ZA, Lauzon G, Maguiness S, 
Dytoc MT. Analysis of interleukin-10 
levels in lesions of vitiligo following 
treatment with topical tacrolimus. 
The British Journal of Dermatology. 
2009;161:654-659
[23] Bassiouny DA, Shaker O. Role of 
interleukin-17 in the pathogenesis of 
vitiligo. Clinical and Experimental 
Dermatology. 2011;36:292-297
[24] Ines D, Sonia B, Riadh BM, Amel 
el G, Slaheddine M, Hamida T, et al. 
A comparative study of oxidant-
antioxidant status in stable and 
active vitiligo patients. Archives 
of Dermatological Research. 
2006;298(4):147-152
[25] Dammak I, Boudaya S, Ben 
Abdallah F, Turki H, Attia H, 
Hentati B. Antioxidant enzymes and 
lipid peroxidation at the tissue level in 
patients with stable and active vitiligo. 
International Journal of Dermatology. 
2009;48:476-480
[26] Hasse S, Gibbons NC, Rokos H, 
Marles LK, Schallreuter KU. Perturbed 
6-tetrahydrobiopterin recycling via 
decreased dihydropteridine reductase 
in vitiligo: More evidence for H2O2 
stress. The Journal of Investigative 
Dermatology. 2004;122:307-313
[27] Shalbaf M, Gibbons NC, Wood JM, 
Maitland DJ, Rokos H, Elwary SM, 
et al. Presence of epidermal allantoin 
further supports oxidative stress in 
vitiligo. Experimental Dermatology. 
2008;17:761-770
[28] Bagherani N, Yaghoobi R, 
Omidian M. Hypothesis: Zinc can be 
effective in treatment of vitiligo. Indian 
Journal of Dermatology. 2011;56:480-484
[29] Yaghoobi R, Omidian M, 
Bagherani N. Vitiligo: A review of 
the published work. The Journal of 
Dermatology. 2011;38:419-431
[30] Hale LP. Zinc alpha-2-glycoprotein 
regulates melanin production by normal 
and malignant melanocytes. The 
Journal of Investigative Dermatology. 
2002;119:464-470
[31] Akbayir N, Gökdemir G, Mansur T, 
Sökmen M, Gündüz S, Alkim C, et al. Is 
there any relationship between hepatitis 
C virus and vitiligo? Journal of Clinical 
Gastroenterology. 2004;38:815-817
[32] Toker SC, Sarycaoglu H, 
Karadogan SK, Mistik R, Baskan EB, 
Tunaly b. Is there any relation between 
vitiligo and cytomegalovirus? Journal of 
the European Academy of Dermatology 
and Venereology. 2007;21:141-142
[33] Niamba P, Traoré A, Taïeb A. 
Vitiligo in a black patient associated 
with HIV infection and repigmentation 
under antiretroviral therapy. Annales 




[34] Lee AY, Youm YH, Kim NH, 
Yang H, Choi WI. Keratinocytes in the 
depigmented epidermis of vitiligo are 
more vulnerable to trauma (suction) 
than keratinocytes in the normally 
pigmented epidermis, resulting in 
their apoptosis. The British Journal of 
Dermatology. 2004;151:995-1003
[35] Bondanza S, Maurelli R, 
Paterna P, Migliore E, Giacomo FD, 
Primavera G, et al. Keratinocyte cultures 
from involved skin in vitiligo 
patients show an impaired in vitro 
behaviour. Pigment Cell Research. 
2007;20:288-300
[36] van den Wijngaard R, Wankowicz- 
Kalinska A, Le Poole C, Tigges B, 
Westerhof W, Das P. Local immune 
response in skin of generalized vitiligo 
patients. Destruction of melanocytes is 
associated with the prominent presence 
of CLA+ T cells at the perilesional 
site. Laboratory Investigation. 
2000;80:1299-1309
[37] Boissy RE, Liu YY, Medrano EE, 
Nordlund JJ. Structural aberration of 
the rough endoplasmic reticulum and 
melanosome compartmentalization 
in long-term cultures of melanocytes 
from vitiligo patients. The Journal 
of Investigative Dermatology. 
1991;97:395-404
[38] Gauthier Y, Cario Andre M, 
Taïeb A. A critical appraisal of vitiligo 
etiologic theories. Is melanocyte loss 
a melanocytorrhagy? Pigment Cell 
Research. 2003;16:322-332
[39] Halder RM, Chappell JL. Vitiligo 
update. Seminars in Cutaneous 
Medicine and Surgery. 2009;28:86-92
[40] Haass NK, Herlyn M. Normal 
human melanocyte homeostasis 
as a paradigm for understanding 
melanoma. The Journal of Investigative 
Dermatology. Symposium Proceedings. 
2005;10:153-163
[41] Lee AY, Kim NH, Choi WI, 
Youm YH. Less keratinocyte-derived 
factors related to more keratinocyte 
apoptosis in depigmented than normally 
pigmented suction blistered epidermis 
may cause passive melanocyte death 
in vitiligo. The Journal of Investigative 
Dermatology. 2005;124:976-983
[42] Le Poole IC, Das PK. Microscopic 
changes in vitiligo. Clinics in 
Dermatology. 1997;15:863-873
[43] Le Poole IC, van den 
Wijngaard RM, Westerhof W, 
Dutrieux RP, Das PK. Presence or 
absence of melanocytes in vitiligo 
lesions: An immunohistochemical 
investigation. The Journal of 
Investigative Dermatology. 
1993;100:816-822
[44] Kim YC, Kim YJ, Kang HY, Sohn S, 
Lee ES. Histopathologic features in 
vitiligo. The American Journal of 
Dermatopathology. 2008;30:112-116
[45] Alikhan A, Felsten LM, 
Daly M, Petronic-Rosic V. Vitiligo: 
A comprehensive overview 
Part I. Introduction, epidemiology, 
quality of life, diagnosis, differential 
diagnosis, associations, histopathology, 
etiology, and work-up. Journal of the 
American Academy of Dermatology. 
2011;65:473-491
[46] Wańkowicz-Kalińska A, van 
den Wijngaard RM, Tigges BJ, 
Westerhof W, Ogg GS, Cerundolo V, 
et al. Immunopolarization of CD4+ and 
CD8+ T cells to Type-1-like is associated 
with melanocyte loss in human 
vitiligo. Laboratory Investigation. 
2003;83:683-695
[47] Boissy RE, Dell'Anna ML, 
Picardo M. On the pathophysiology of 
vitiligo: Possible treatment options. 
Indian Journal of Dermatology, 
Venereology and Leprology. 
2012;78:24-29
11
Histopathology and Molecular Pathology of Vitiligo
DOI: http://dx.doi.org/10.5772/intechopen.84258
[48] van den Boorn JG, 
Konijnenberg D, Dellemijn TA, van 
der Veen JP, Bos JD, Melief CJ, et al. 
Autoimmune destruction of skin 
melanocytes by perilesional T cells 
from vitiligo patients. The Journal 
of Investigative Dermatology. 
2009;129:2220-2232
[49] Yadav AK, Singh P, Khunger N. 
Clinicopathologic analysis of stable 
and unstable vitiligo: A study of 
66 cases. The American Journal of 
Dermatopathology. 2016;38(8):608-613
